🇺🇸 FDA
Patent

US 9540337

Gamma-glutamyl transpeptidase inhibitors and methods of use

granted A61KA61K31/433

Quick answer

US patent 9540337 (Gamma-glutamyl transpeptidase inhibitors and methods of use) held by The Board of Regents of the University of Oklahoma expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/433